NCT04868708 2025-03-04A Study of AK104( an Anti-PD-1 and Anti-CTLA-4 Bispecific Antibody) in Recurrent or Metastatic Cervical CancerAkesoPhase 2 Completed50 enrolled
NCT03530397 2024-06-24A Study to Evaluate MEDI5752 in Subjects With Advanced Solid TumorsMedImmune LLCPhase 1 Active not recruiting401 enrolled